# Acta Pharmaceuticals, Inc. — Form D

Acta Pharmaceuticals, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-07. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2023-04-07
- Form: D
- Accession: 0001972861-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.0M
- Remaining: $5.0M
- Investors: 16
- Date of first sale: 2023-03-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-478258

## Issuer

- Name: Acta Pharmaceuticals, Inc.
- CIK: 0001972861
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 292 NEWBURY STREET, BOSTON, MA, 02115
- Phone: 8579302282

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Rudolph Tanzi | Executive Officer | Boston, MA |
| George Alex | Promoter | Boston, MA |
| Rudolph Tanzi | Promoter | Boston, MA |
| Thierry Porte | Director | ST. HELIER, Y9 |
| George Alex | Director | Boston, MA |
| George Alex | Executive Officer | Boston, MA |
| Rudolph Tanzi | Director | Boston, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-04-22](https://search.stillhousedata.com/formd/0001972861-24-000001) | D/A | $17.5M | $13.4M |

## More

- [CIK 1972861 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1972861&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001972861-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.